Browsing Tag
Lapam Capital
1 post
Chance Pharmaceuticals raises $30m in Series C for inhalation therapies
Chance Pharmaceuticals, a Chinese clinical-stage biotech company focused on inhalation therapies for debilitating diseases, has raised $30 million…